DT 7012
Alternative Names: Anti-C-C motif chemokine receptor 8 antibody - Domain Therapeutics; Anti-CCR8 antibody - Domain Therapeutics; DT-7012Latest Information Update: 12 Jun 2024
Price :
$50 *
At a glance
- Originator Domain Therapeutics
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Regulatory T-lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cancer